These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3367648)

  • 1. Simple pA2 estimation of partial agonists: comparison with the Kaumann-Blinks method.
    Pöch G; Zimmermann I
    J Pharmacol Methods; 1988 Mar; 19(1):47-56. PubMed ID: 3367648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
    Pöch G; Brunner F; Kühberger E
    Br J Pharmacol; 1992 Jul; 106(3):710-6. PubMed ID: 1504755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Schild regression in the process of receptor classification.
    Kenakin TP
    Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antinoradrenergic activity of raubasine on isolated thoracic aorta and vas deferens of rat (author's transl)].
    Roquebert J; Gomond P; Demichel P
    J Pharmacol; 1981; 12(4):393-403. PubMed ID: 6119400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor theories and quantitative effect versus dose-concentration relationship.
    Tallarida RJ
    Drug Metab Rev; 1984; 15(1-2):345-63. PubMed ID: 6745084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves.
    Pöch G; Holzmann S
    J Pharmacol Methods; 1980 Sep; 4(2):179-88. PubMed ID: 7453194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of agonist-agonist interactions: the crucial influence of curve shape.
    Scaramellini C; Bennett G; Leff P
    J Pharmacol Toxicol Methods; 1997 Apr; 37(3):167-78. PubMed ID: 9253753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor partial agonism and method to express receptor partial activation with respect to novel Full Logistic Model of mixture toxicology.
    Ezechiáš M; Cajthaml T
    Toxicology; 2018 Jan; 393():26-33. PubMed ID: 29079363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophages.
    Schenkelaars EJ; Bonta IL
    Eur J Pharmacol; 1984 Dec; 107(1):65-70. PubMed ID: 6151905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
    Cardell LO; Edvinsson L
    Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the affinity of naloxone at supraspinal and spinal opioid receptors in vivo: studies with receptor selective agonists.
    Heyman JS; Koslo RJ; Mosberg HI; Tallarida RJ; Porreca F
    Life Sci; 1986 Nov; 39(19):1795-803. PubMed ID: 3022095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
    Calderone V; Baragatti B; Breschi MC; Martinotti E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of the potencies of GABA-receptor agonists and antagonists using the rat hippocampal slice preparation.
    Kemp JA; Marshall GR; Woodruff GN
    Br J Pharmacol; 1986 Apr; 87(4):677-84. PubMed ID: 3011168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
    MacEwan DJ; Kim GD; Milligan G
    Mol Pharmacol; 1995 Aug; 48(2):316-25. PubMed ID: 7651365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transition of drug receptor mechanisms].
    Takayanagi I; Koike K; Satoh M
    J Smooth Muscle Res; 1992 Apr; 28(2):35-54. PubMed ID: 1327301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insight into isobolographic analysis for combinations of a full and partial agonist: Curved isoboles.
    Ezechiáš M; Cajthaml T
    Toxicology; 2018 Jun; 402-403():9-16. PubMed ID: 29660376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the coexistence of beta 1- and beta 2-adrenoceptors in various organs.
    Wagner J; Nick B; Rohm N; Schümann HJ
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):26-38. PubMed ID: 6261704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative estimation of potentiation and antagonism by dose ratios corrected for slopes of dose-response curves deviating from one.
    Pöch G; Reiffenstein RJ; Baer HP
    J Pharmacol Toxicol Methods; 1995 Aug; 33(4):197-204. PubMed ID: 8527827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.